SOPHiA GENETICS SA (SOPH) Tops Q3 EPS by 8c

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $15.63 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• RH (RH) Tops Q1 EPS by 12c
• Carvana (CVNA) PT Lowered to $85 at RBC Capital